Cargando…
Psoriasis and uveitis: links and risks
Uveitis, an inflammatory disorder of the mid-portion of the eye, is considered a relatively rare but very serious ocular complication of psoriasis. Data on the specific characteristics of uveitis in the background of psoriasis are extremely limited. The presence of uveitis in the context of psoriasi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717847/ https://www.ncbi.nlm.nih.gov/pubmed/31696050 http://dx.doi.org/10.2147/PTT.S179182 |
_version_ | 1783447625527197696 |
---|---|
author | Fotiadou, Christina Lazaridou, Elizabeth |
author_facet | Fotiadou, Christina Lazaridou, Elizabeth |
author_sort | Fotiadou, Christina |
collection | PubMed |
description | Uveitis, an inflammatory disorder of the mid-portion of the eye, is considered a relatively rare but very serious ocular complication of psoriasis. Data on the specific characteristics of uveitis in the background of psoriasis are extremely limited. The presence of uveitis in the context of psoriasis has been estimated to occur in 7–20% of the psoriasis cases. This incidence tends to be higher in patients suffering from psoriasis and psoriatic arthritis (PsA) or PSA alone. Psoriatic uveitis is usually bilateral, chronic, and severe. In term of pathogenesis, both psoriasis and uveitis are considered as paradigms of T-helper 1/T-helper 17 (Th1/Th17) inflammatory reactions. Certain cytokines such as tumor necrosis factor-α (TNF- α), Interleukin-17 (IL-17), IL-23, and IL-6 play a significant role in the pathogenesis of both psoriasis and uveitis. As uveitis shares common pathogenetic mechanisms with psoriasis in certain circumstances, both diseases may benefit from the same targeted biologic therapies. Undiagnosed and under-treated cases of psoriatic uveitis may cause significant morbidity and even vision loss. Larger prospective studies are needed in order to further investigate the association between these two entities. |
format | Online Article Text |
id | pubmed-6717847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-67178472019-11-06 Psoriasis and uveitis: links and risks Fotiadou, Christina Lazaridou, Elizabeth Psoriasis (Auckl) Review Uveitis, an inflammatory disorder of the mid-portion of the eye, is considered a relatively rare but very serious ocular complication of psoriasis. Data on the specific characteristics of uveitis in the background of psoriasis are extremely limited. The presence of uveitis in the context of psoriasis has been estimated to occur in 7–20% of the psoriasis cases. This incidence tends to be higher in patients suffering from psoriasis and psoriatic arthritis (PsA) or PSA alone. Psoriatic uveitis is usually bilateral, chronic, and severe. In term of pathogenesis, both psoriasis and uveitis are considered as paradigms of T-helper 1/T-helper 17 (Th1/Th17) inflammatory reactions. Certain cytokines such as tumor necrosis factor-α (TNF- α), Interleukin-17 (IL-17), IL-23, and IL-6 play a significant role in the pathogenesis of both psoriasis and uveitis. As uveitis shares common pathogenetic mechanisms with psoriasis in certain circumstances, both diseases may benefit from the same targeted biologic therapies. Undiagnosed and under-treated cases of psoriatic uveitis may cause significant morbidity and even vision loss. Larger prospective studies are needed in order to further investigate the association between these two entities. Dove 2019-08-28 /pmc/articles/PMC6717847/ /pubmed/31696050 http://dx.doi.org/10.2147/PTT.S179182 Text en © 2019 Fotiadou and Lazaridou. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Fotiadou, Christina Lazaridou, Elizabeth Psoriasis and uveitis: links and risks |
title | Psoriasis and uveitis: links and risks |
title_full | Psoriasis and uveitis: links and risks |
title_fullStr | Psoriasis and uveitis: links and risks |
title_full_unstemmed | Psoriasis and uveitis: links and risks |
title_short | Psoriasis and uveitis: links and risks |
title_sort | psoriasis and uveitis: links and risks |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717847/ https://www.ncbi.nlm.nih.gov/pubmed/31696050 http://dx.doi.org/10.2147/PTT.S179182 |
work_keys_str_mv | AT fotiadouchristina psoriasisanduveitislinksandrisks AT lazaridouelizabeth psoriasisanduveitislinksandrisks |